Boyd Wealth Management’s AbbVie ABBV Stock Holding History

Boyd Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$208K	Buy	+793	New	+$203K	0.07%	62
2026 Q2	–	Sell	-1,140	Closed	-$248K	–	48
2026 Q1	$248K	Hold	1,140	–	–	0.1%	46
2025 Q4	$261K	Hold	1,140	–	–	0.11%	44
2025 Q3	$264K	Sell	1,140 -47	-4%	-$9.6K	0.11%	45
2025 Q2	$220K	Hold	1,187	–	–	0.1%	50
2025 Q1	$249K	Hold	1,187	–	–	0.12%	41
2024 Q4	$211K	Buy	+1,187	New	+$218K	0.1%	47

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Boyd Wealth Management's ABBV Position: Q3 2026 in Review

Boyd Wealth Management opened a new position in AbbVie (ABBV) in Q3 2026: 793 shares worth $208K. The stake represents 0.07% of the portfolio and ranks #62 among its holdings. This is a return to the name: Boyd Wealth Management previously reported a position in ABBV as recently as Q1 2026.

Boyd Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $264K in Q3 2025. 1,209 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Boyd Wealth Management held 793 shares of AbbVie worth $208K as of Q3 2026.
AbbVie was a new Boyd Wealth Management position in Q3 2026.
AbbVie made up 0.07% of Boyd Wealth Management's portfolio in Q3 2026, its #62 holding.
Boyd Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Boyd Wealth Management's AbbVie position peaked at $264K in Q3 2025.
1,209 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Boyd Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.